SCA
ARKG icon

Snowden Capital Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Snowden Capital Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-69,145
Closed -$2.27M – 1173
2023
Q4 		$2.27M Sell
69,145
-1,337
-2% -$36.4K 0.09% 264
2023
Q3 		$1.96M Sell
70,482
-2,070
-3% -$67.7K 0.08% 273
2023
Q2 		$2.47M Sell
72,552
-929
-1% -$29.2K 0.09% 256
2023
Q1 		$2.21M Sell
73,481
-28,420
-28% -$881K 0.09% 265
2022
Q4 		$2.88M Sell
101,901
-1,714
-2% -$54.4K 0.12% 214
2022
Q3 		$3.4M Sell
103,615
-3,496
-3% -$128K 0.15% 171
2022
Q2 		$3.37M Sell
107,111
-101
-0.1% -$3.53K 0.15% 180
2022
Q1 		$4.92M Buy
107,212
+3,358
+3% +$160K 0.2% 137
2021
Q4 		$6.36M Buy
103,854
+255
+0.2% +$17.6K 0.32% 78
2021
Q3 		$7.74M Buy
103,599
+2,064
+2% +$173K 0.39% 57
2021
Q2 		$9.39M Buy
101,535
+1,358
+1% +$115K 0.47% 39
2021
Q1 		$8.89M Buy
100,177
+2,192
+2% +$217K 0.51% 30
2020
Q4 		$9.14M Buy
97,985
+20,632
+27% +$1.64M 0.6% 26
2020
Q3 		$4.93M Sell
77,353
-79,969
-51% -$4.69M 0.39% 70
2020
Q2 		$8.21M Buy
157,322
+24,978
+19% +$1.07M 0.7% 22
2020
Q1 		$4.14M Buy
132,344
+13,734
+12% +$459K 0.45% 51
2019
Q4 		$3.98M Buy
118,610
+5,762
+5% +$183K 0.35% 80
2019
Q3 		$3.33M Sell
112,848
-8,652
-7% -$281K 0.34% 94
2019
Q2 		$4.19M Buy
121,500
+38,895
+47% +$1.25M 0.43% 61
2019
Q1 		$2.72M Buy
82,605
+20,064
+32% +$592K 0.3% 114
2018
Q4 		$1.5M Buy
62,541
+10,535
+20% +$297K 0.19% 180
2018
Q3 		$1.74M Buy
+52,006
New +$1.65M 0.2% 167

Other funds holding ARKG

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Snowden Capital Advisors's ARKG Position: Q1 2024 in Review

Snowden Capital Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2024, closing a stake of 69,145 shares — an estimated $2.27M sold.

Snowden Capital Advisors first reported a position in ARKG in Q3 2018 and held it in 22 quarters. The position peaked at $9.39M in Q2 2021. 284 funds tracked by Wall St. Rank hold ARKG as of Q1 2024.

  • Snowden Capital Advisors reported no remaining ARK Genomic Revolution ETF position as of Q1 2024 after selling out during the quarter.
  • Snowden Capital Advisors sold 69,145 ARK Genomic Revolution ETF shares in Q1 2024, an estimated $2.27M.
  • Snowden Capital Advisors first reported a position in ARK Genomic Revolution ETF in Q3 2018 and held it in 22 quarters.
  • Snowden Capital Advisors's ARK Genomic Revolution ETF position peaked at $9.39M in Q2 2021.
  • 284 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2024.

Based on Snowden Capital Advisors's 13F filing for Q1 2024, filed 15 May 2024.